These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9463297)

  • 1. [In vitro influence of biologically active factors of microorganisms on antibiotic susceptibility of Yersinia pestis].
    Zurabyan VA; Pavlovich NV; Makarovskaya LN; Ryzhkova VV; Bugaeva OK
    Antibiot Khimioter; 1997; 42(11):22-5. PubMed ID: 9463297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotic sensitivity of plague microbe strains from foreign countries].
    Galenko GN; Akiev AK; Tarasova VE
    Antibiot Khimioter; 1992 Nov; 37(11):23-4. PubMed ID: 1300928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibiotic sensitivity of strains of the plague microbe isolated from foci in the Caucasus and Transcaucasia].
    Tarasova VE; Eremitskaia GN; Proskurina VA
    Antibiotiki; 1981 May; 26(5):365-7. PubMed ID: 7259143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
    Wendte JM; Ponnusamy D; Reiber D; Blair JL; Clinkenbeard KD
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3752-7. PubMed ID: 21628541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of rifampicin in experimental plague infection].
    Makarovskaia LN; Shcherbaniuk AI; Bugaeva OK
    Antibiot Khimioter; 1993 Jul; 38(7):34-6. PubMed ID: 8161275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.
    Frean JA; Arntzen L; Capper T; Bryskier A; Klugman KP
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2646-7. PubMed ID: 8913481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection.
    Russell P; Eley SM; Green M; Stagg AJ; Taylor RR; Nelson M; Beedham RJ; Bell DL; Rogers D; Whittington D; Titball RW
    J Antimicrob Chemother; 1998 Feb; 41(2):301-5. PubMed ID: 9533478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents.
    Hernandez E; Girardet M; Ramisse F; Vidal D; Cavallo JD
    J Antimicrob Chemother; 2003 Dec; 52(6):1029-31. PubMed ID: 14613959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the effectiveness of antibacterial substances in treating an experimental form of bubonic plague in monkeys].
    Romanov VE; Evstigneev VI; Vasil'ev NT; Shabalin BA; Paramonov VE
    Antibiot Khimioter; 2001; 46(8):6-8. PubMed ID: 11871319
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Steenbergen J; Tanaka SK; Miller LL; Halasohoris SA; Hershfield JR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta-lactam antibiotics (ampicillin, cefotaxime) in prevention of experimental plague in albino mice, caused by non-fractioned strains of the pathogen].
    Samokhodkina ED; Ryzhko IV; Tsuraeva RI; Pasiukov VV
    Antibiot Khimioter; 1994 Jul; 39(7):20-3. PubMed ID: 7840704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synergistic action of some antibacterial agents in studies on albino mice with experimental plague caused by Fr- phenotype strain of the plague microbe].
    Shcherbaniuk AI; Liukshina EIu; Ryzhko IV; Smorodinova IuV
    Antibiot Khimioter; 2006; 51(1):7-10. PubMed ID: 16734358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detoxifying effect of antibiotics and their effectiveness in experimental plague at the stage of explicit intoxication].
    Makarovskaia LN; Glian'ko EV; Tinker LA; Kasatkin IuA; Ryzhkova VV; Bozhko NV; Kozyreva LA
    Antibiot Khimioter; 1992 Nov; 37(11):30-2. PubMed ID: 1300933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of subinhibitory concentrations of antibiotics on catalase activity of plague microbes].
    Ryzhkova VV; Blagorodova NS; Mikhalevich RV; Pavlovich NV
    Antibiot Khimioter; 1992 Nov; 37(11):21-3. PubMed ID: 1300927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The sensitivity of plague agent from Siberian natural focuses of disease to antibacterial preparations in vitro].
    Balakhonov SV; Bel'kova SA; Tokmakova EG; Khvoĭnova IG; Zakhlebnaia OD
    Klin Lab Diagn; 2013 Apr; (4):36-40. PubMed ID: 23984554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.
    Bonacorsi SP; Scavizzi MR; Guiyoule A; Amouroux JH; Carniel E
    Antimicrob Agents Chemother; 1994 Mar; 38(3):481-6. PubMed ID: 8203841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antimicrobial susceptibilities of strains of Yersinia pestis.
    Smith MD; Vinh DX; Nguyen TT; Wain J; Thung D; White NJ
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2153-4. PubMed ID: 8540736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice].
    Ryzhko IV; Tsuraeva RI; Pasiukov VV; Samokhodkina ED; Shcherbaniuk AI
    Antibiot Khimioter; 1996 May; 41(5):35-8. PubMed ID: 9054316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods.
    Heine HS; Hershfield J; Marchand C; Miller L; Halasohoris S; Purcell BK; Worsham PL
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1919-21. PubMed ID: 25583720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory studies on Yersinia pestis during the 1991 outbreak of plague in Lushoto, Tanzania.
    Lyamuya EF; Nyanda P; Mohammedali H; Mhalu FS
    J Trop Med Hyg; 1992 Oct; 95(5):335-8. PubMed ID: 1404556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.